Form D · Pharmaceuticals
Osteologix, Inc.
Glen Allen, VA · CIK 0001278129
Offering snapshot reported Jun 14, 2010 · SEC filing
- Reported sold
- $750K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 11, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2010 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Jan 28, 2010 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Apr 30, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-143473
Source: Form D, filed Jun 14, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John M. Barberich | Director |
| Jeremy Curnock Cook | Director |
| Klaus Eldrup Jorgensen | Director |
| Bobby W. Sandage, Jr. | Director |
| Philip J. Young | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4415 Cox Road
Glen Allen, VA, 23060
Glen Allen, VA, 23060